[Cancer Management and Research] A meta-analysis of randomized controlled trials sought to confirm the effectiveness and safety of olaparib for the treatment of relapsed BRCA-mutated ovarian cancer.
[Cancer Management and Research] A review of data from clinical trials on the use of carfilzomib, a second-generation PI, in the treatment of R/R multiple myeloma, as well as ongoing studies and prescribing advice.
A review of durvalumab, an immune checkpoint inhibitor approved for the treatment of urothelial carcinoma.
[Cancer Management and Research] A review of 14 cases in which patients with well-differentiated thyroid cancer experienced adverse outcomes after surgical treatment of their disease.
[Cancer Management and Research] Chinese researchers present a review of a rare cancer and strategies for managing the most common adverse effect of its treatment.
[Lung Cancer: Targets and Therapy] A review of pathophysiology of pain and pharmaceutical and nonpharmaceutical treatment options for managing pain in patients with this rare disease.
[OncoTargets and Therapy] This review addresses common questions facing the clinician and patient, and provide an update on new strategies for Ewing Sarcoma therapy.
[OncoTargets and Therapy] Researchers examine the main mechanisms of drug resistance currently being studied, including drug resistance-related proteins and enzymes, gene alterations, micro RNAs, and signal pathways.
[Cancer Management and Research] Accumulating evidences showed some positive relations between MI and new onset cancer.
[Breast Cancer: Targets and Therapy] A review of conventional and novel therapies for breast cancer, as well as an investigation into the role of breast cancer stem cells in treatment resistance and what’s in the pipeline to combat that resistance.
